Chaja F. Jacobs
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia.
Journal: Cellular & molecular immunology
Published: August 23, 2024
Radiological, pathological and surgical outcomes after neoadjuvant endocrine treatment in patients with ER-positive/HER2-negative breast cancer with a clinical high risk and a low-risk 70-gene signature.
Journal: Breast (Edinburgh, Scotland)
Published: February 08, 2024
Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease.
Journal: Blood advances
Published: January 12, 2024
Concurrent chemo-endocrine treatment for early hormone-positive breast cancer: a no-go???
Journal: Breast cancer research and treatment
Published: October 06, 2021
Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576.
Journal: Advances in hematology
Published: September 08, 2021
Ibrutinib reduces obinutuzumab infusion-related reactions in patients with chronic lymphocytic leukemia and is associated with changes in plasma cytokine levels.
Journal: Haematologica
Published: May 03, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026